A slight trend in the norketamine model fit at the inhibitor phase can be attributed to the fast metabolism to secondary metabolites, but also to the marked between‐subject variability in the S ‐ketamine metabolism.
← all excerpts
Semimechanistic Population Pharmacokinetic Model to Predict the Drug-Drug Interaction Between S-ketamine and Ticlopidine in Healthy Human Volunteers.
1
—
—